Miriam Klausberger

Lectures

• Year: 2023 -  Bioseparation of enveloped virus-like particles with different surface antigens by a heparin affinity chromatography platform process

  Autoren: Alexander Zollner, Leticia Guzman Ruiz, Viktoria Mayer, Nico Lingg, Miriam Klausberger, Alois Jungbauer, Patricia Pereira Aguilar

  Event: 25th Meeting of the International Society for Molecular Recognition - Affinity 2023

• Year: 2022 -  Novel purification strategies for Influenza neuraminidase-VLPs

  Autoren: Guzmán-Ruiz, Leticia; Klausberger, Miriam; Krammer, Florian; Jungbauer, Alois; Grabherr, Reingard

  Event: 8th Conference Vaccine Technology 2022

• Year: 2022 -  SARS-CoV-2 receptor binding domain (RBD) designs for homogenous monomeric antigen preparations

  Autoren: Klausberger, M; Kienzl, N; Stadlmayr, G; Mach, L; Wozniak-Knopp, G

  Event: 16th Vaccine Congress 2022

• Year: 2022 -  Superior SARS-CoV-2 RBD antigen designs for highly specific, quantitative serotests

  Autoren: Klausberger, M; Dürkop, M; Kienzl, N; Stadlmayr, G; Mach, L; Wozniak-Knopp, G; Grabherr, R

  Event: 8th Conference Vaccine Technology 2022

• Year: 2022 -  Production of influenza virus-like particles by insect cells and removal of baculovirus from virus-like particles and other extracellular vesicles

  Autoren: Jungbauer, A; Aguilar, P; Lingg, N; 1, Klausberger, M; Strobl, F; Ernst, W; Striedner, G; Grabherr R

  Event: Vaccine Technology

• Year: 2021 -  Impact of Specific N-Glycan Modifications on the Use of Plant-Produced SARS-CoV-2 Antigens in Serological Assays

  Autoren: Schwestka, J., König-Beihammer, J., Shin Y.J., Vavra, U., Melnik, S., Kienzl, N.F., Grünwald-Gruber, C., Maresch, D., Klausberger, M., Laurent, E., Stadler, M., Manhart, G., Huber, J., Hofner, M., Vierlinger, K., Weinhäusel, A., Swoboda, I., Binder, C.J., Gerner, W., Grebien, F., Altmann, F., Mach, L., Stöger, E. and Strasser, R.

  Event: 4th ISPMF Conference

• Year: 2020 -  Development, assessment and commercialization of serological SARS CoV-2 tests - an interdisciplinary success story

  Autoren: Duerkop, M; Klausberger, M

  Event: Labroots - Coronavirus Virtual Event

• Year: 2020 -  Development, assessment and commercialization of serological SARS CoV-2 tests „made in Austria”

  Autoren: Duerkop, M, Klausberger, M; Cserjan, M; Gerner, W; Grebien, F; Binder, C; March, L;

  Event: ÖGMBT Anual Meeting 2020

• Year: 2019 -  Off-Target Effects of Immunity Conferred by Insect Cell- Expressed Influenza HA-VLPs on Secondary Bacterial Infections

  Autoren: Klausberger, M; Leneva, IA; Egorov, AY; Linder, C; Vasiliev, K; Falynskova, IN; Poddubikov, AV; Grabherr, R

  Event: Options for the Control of Influenza X

• Year: 2019 -  Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia

  Autoren: Falynskova, I; Leneva, I; Egorov, A; Poddubikov, A; Grabherr, R; Klausberger, M

  Event: European-Respiratory-Society (ERS) International Congress

• Year: 2019 -  Investigating the off-target effects of influenza HA-specific immunity on secondary pneumococcal infections

  Autoren: Klausberger, M

  Event: European Summit of Industrial Biotechnology ESIB 2019

• Year: 2018 -  A baculovirus-mediated CRISPR/Cas9 platform in Sf9 insect cells

  Autoren: Klausberger, M; Heindl, M; Ernst, W; Grabherr, R

  Event: Virus-Like Particle & Nano-Particle Vaccines

• Year: 2017 -  Quantification of Virus-like Particles by High Performance Size-exclusion Chromatography and Nanoparticle Tracking Analysis

  Autoren: Steppert, P; Burgstaller, D; Klausberger, M; Jungbauer, A

  Event: 11th Balaton Symposium on High-Performance Separation Methods 2017

• Year: 2015 -  Efficacy and immunogenicity of an insect cell-derived virus-like particle vaccine for avian influenza H7N9 virus in mice

  Autoren: Klausberger, M; Palmberger, D; Grabherr, R; Krammer, F

  Event: 40th Congress of the Federation-of-European-Biochemical-Societies (FEBS) - The Biochemical Basis of Life

• Year: 2013 -  Efficacy and immunogenicity of an insect cell-derived virus-like particle vaccine for the novel Chinese H7N9 influenza virus in mice.

  Autoren: Klausberger, M., Palmberger, D., Grabherr, R., Krammer, F.

  Event: Influenza 2013: One Influenza, One World, One Health

• Year: 2013 -  Comparative analysis of three insect cell lines - Sf9, High Five and Tnao38 - for the production of influenza A virus-like particles.

  Autoren: Klausberger, M., Wilde, M., Palmberger, M., Ernst, W., Grabherr, R.

  Event: ÖGMBT Meeting

• Year: 2012 -  Evaluation of three insect cell lines - Sf9, High Five and Tnao38 - for the production of influenza A virus-like particles (VLPs)

  Autoren: Klausberger, M., Palmberger, D., Wilde, M., Grabherr, R.

  Event: Virus-Like Particle & Nano-Particle Vaccines VLPNPV 2012

• Year: 2012 -  Virus-like particles as carrier for cancer antigen peptide mimics

  Autoren: Klausberger, M., Wilde, M., Palmberger, D., Ernst, W., Grabherr, R.

  Event: 4th ÖGMBT Annual Meeting 2012

• Year: 2012 -  A novel virus-like particle-based anticancer vaccine using the mimotope strategy

  Autoren: Klausberger, M; Wilde, M; Palmberger, D; Ernst, W; Grabherr, R

  Event: European Congress of Immunology 2012

• Year: 2010 -  Characterization of a FAD dependent glucose dehydrogenase for mediated reductase reactions

  Autoren: Klausberger, M., C. Sygmund, D. Haltrich, R. Ludwig

  Event: Biocatalysis and Medicinal Chemistry 2010 - Crossroads and Synergies